Connor, Clark & Lunn Investment Management (CC&L)
PRAX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Praxis Precision Medicines PRAX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PRAX Stock Details PRAX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.02M Buy
2024
Q2 		– Sell
2024
Q1 		$343K Sell
2023
Q4 		$257K Buy
2023
Q3 		$96K Buy
2023
Q2 		$44.5K Buy